INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 49m ago
HOUSE PTR9m ago
SEC 13F9m ago
ROBINHOOD CHAIN9m ago
Corporate insider
AK

Alam Kamran

CHIEF FINANCIAL OFFICERCIK 0001793412

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL$375K
79.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Taysha Gene Therapies, Inc.CHIEF FINANCIAL OFFICER · Jan 14, 2026
25
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Open-market sale
SELL
$110K
23.8K sh
Jan 26, 2026
Jan 27, 2026
traded Jan 26, 2026
+1d
SEC FORM 4

Evidence

17
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Grant or award
A—
359.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC FORM 4

Evidence

9
AK
Alam KamranCHIEF FINANCIAL OFFICER
TSHATaysha Gene Therapies, Inc.
Grant or award
A—
231.0K sh
Jan 12, 2026Jan 14, 2026
traded Jan 12, 2026
+2dSEC FORM 4

Evidence